Viewing Study NCT04697056


Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2026-01-06 @ 6:07 AM
Study NCT ID: NCT04697056
Status: TERMINATED
Last Update Posted: 2025-09-16
First Post: 2020-12-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis
Sponsor: Vanda Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ichthyosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None IL-36 Receptor View
None Interleukin 36 View
None Imsidolimab View